Affymetrix's Shares Jump 30 Percent in June to Lead GWDN Index | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Affymetrix climbed 30 percent in June after the firm announced early in the month that Frank Witney had rejoined the company, replacing Kevin King as president and CEO.

Affymetrix, which is currently trading at a 52-week high, led all shares in the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.